用于基因递送的脂质纳米颗粒。
Lipid nanoparticles for gene delivery.
作者信息
Zhao Yi, Huang Leaf
机构信息
Division of Molecular Pharmaceutics and Center for Nanotechnology in Drug Delivery, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
出版信息
Adv Genet. 2014;88:13-36. doi: 10.1016/B978-0-12-800148-6.00002-X.
Abstract
Nonviral vectors which offer a safer and versatile alternative to viral vectors have been developed to overcome problems caused by viral carriers. However, their transfection efficacy or level of expression is substantially lower than viral vectors. Among various nonviral gene vectors, lipid nanoparticles are an ideal platform for the incorporation of safety and efficacy into a single delivery system. In this chapter, we highlight current lipidic vectors that have been developed for gene therapy of tumors and other diseases. The pharmacokinetic, toxic behaviors and clinic trials of some successful lipids particles are also presented.
摘要
为克服病毒载体所带来的问题，已开发出比病毒载体更安全、用途更广泛的非病毒载体。然而，它们的转染效率或表达水平远低于病毒载体。在各种非病毒基因载体中，脂质纳米颗粒是将安全性和有效性整合到单一递送系统中的理想平台。在本章中，我们重点介绍了目前已开发用于肿瘤和其他疾病基因治疗的脂质载体。还介绍了一些成功的脂质颗粒的药代动力学、毒性行为和临床试验情况。
相似文献
1
Lipid nanoparticles for gene delivery.用于基因递送的脂质纳米颗粒。
Adv Genet. 2014;88:13-36. doi: 10.1016/B978-0-12-800148-6.00002-X.
2
Lipid-coated calcium phosphate nanoparticles for nonviral gene therapy.用于非病毒基因治疗的脂质包被磷酸钙纳米颗粒。
Adv Genet. 2014;88:205-29. doi: 10.1016/B978-0-12-800148-6.00007-9.
3
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration.非病毒癌症基因治疗：递药级联和载体纳米特性整合。
Adv Drug Deliv Rev. 2017 Jun 1;115:115-154. doi: 10.1016/j.addr.2017.07.021. Epub 2017 Aug 1.
4
Nanoparticles as nonviral gene delivery vectors.纳米颗粒作为非病毒基因递送载体。
IEEE Trans Nanobioscience. 2007 Dec;6(4):319-30. doi: 10.1109/tnb.2007.908996.
5
Lipid-based nanoparticles in the systemic delivery of siRNA.用于siRNA全身递送的脂质基纳米颗粒。
Nanomedicine (Lond). 2014 Jan;9(1):105-20. doi: 10.2217/nnm.13.192.
6
Preparation of lipid:peptide:DNA (LPD) nanoparticles and their use for gene transfection.脂质：肽：DNA（LPD）纳米颗粒的制备及其在基因转染中的应用。
Methods Mol Biol. 2012;906:329-36. doi: 10.1007/978-1-61779-953-2_27.
7
Nonviral vectors: we have come a long way.非病毒载体：我们已经取得了长足的进步。
Adv Genet. 2014;88:1-12. doi: 10.1016/B978-0-12-800148-6.00001-8.
8
Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy.磷酸钙纳米颗粒：基因治疗中的第二代非病毒载体
Expert Rev Mol Diagn. 2005 Nov;5(6):893-905. doi: 10.1586/14737159.5.6.893.
9
Recent advances in nonviral vectors for gene delivery.基因传递的非病毒载体的最新进展。
Acc Chem Res. 2012 Jul 17;45(7):971-9. doi: 10.1021/ar200151m. Epub 2011 Aug 26.
10
Applications of lipid nanoparticles in gene therapy.脂质纳米颗粒在基因治疗中的应用。
Eur J Pharm Biopharm. 2016 Dec;109:184-193. doi: 10.1016/j.ejpb.2016.10.016. Epub 2016 Oct 24.
引用本文的文献
1
Controlling CRISPR-Cas9 genome editing in human cells using a molecular glue degrader.使用分子胶降解剂控制人类细胞中的CRISPR-Cas9基因组编辑。
Mol Ther Nucleic Acids. 2025 Jul 21;36(3):102640. doi: 10.1016/j.omtn.2025.102640. eCollection 2025 Sep 9.
2
Engineering Nanoparticles and Bioscaffolds for Targeted microRNA Delivery in Cardiovascular Regeneration-A Comprehensive Review.用于心血管再生中靶向递送微小RNA的工程纳米颗粒和生物支架——综述
FASEB J. 2025 Jul 31;39(14):e70871. doi: 10.1096/fj.202501226RR.
3
Assessment of the Effects of Ionizing Radiation on Biologic Drugs: mAb Product Quality and Risk Evaluation for Global Shipping Logistics.电离辐射对生物药物的影响评估：单克隆抗体产品质量及全球运输物流的风险评估
Pharm Res. 2025 May 16. doi: 10.1007/s11095-025-03867-7.
4
PEGylated Liposomes of Disulfiram and Paclitaxel: A Promising Chemotherapeutic Combination Against Chemoresistant Breast Cancer.双硫仑与紫杉醇的聚乙二醇化脂质体：一种针对化疗耐药性乳腺癌的有前景的化疗组合。
Pharmaceuticals (Basel). 2025 Mar 28;18(4):487. doi: 10.3390/ph18040487.
5
Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation.脂质纳米颗粒靶向中性粒细胞以减轻新冠病毒诱导的肺损伤和炎症。
J Control Release. 2025 Jun 10;382:113736. doi: 10.1016/j.jconrel.2025.113736. Epub 2025 Apr 18.
6
A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA.癌症免疫治疗的新范式：靶向免疫原性细胞死亡相关非编码RNA
Front Immunol. 2025 Jan 23;15:1498781. doi: 10.3389/fimmu.2024.1498781. eCollection 2024.
7
The role of nanoparticles in transforming plant genetic engineering: advancements, challenges and future prospects.纳米颗粒在植物基因工程转化中的作用：进展、挑战与未来前景
Funct Integr Genomics. 2025 Jan 22;25(1):23. doi: 10.1007/s10142-025-01528-x.
8
Polymeric Vehicles for Nucleic Acid Delivery: Enhancing the Therapeutic Efficacy and Cellular Uptake.聚合物载体用于核酸递送：增强治疗效果和细胞摄取。
Recent Adv Drug Deliv Formul. 2024;18(4):276-293. doi: 10.2174/0126673878324536240805060143.
9
Placental Gene Therapy for Fetal Growth Restriction and Preeclampsia: Preclinical Studies and Prospects for Clinical Application.用于胎儿生长受限和子痫前期的胎盘基因治疗：临床前研究及临床应用前景
J Clin Med. 2024 Sep 23;13(18):5647. doi: 10.3390/jcm13185647.
10
Exploring delivery systems for targeted nanotechnology-based gene therapy in the inner ear.探索内耳中基于靶向纳米技术的基因治疗的递药系统。
Ther Deliv. 2024;15(10):801-818. doi: 10.1080/20415990.2024.2389032. Epub 2024 Sep 26.
本文引用的文献
1
Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity.具有可预测体内siRNA递送活性的可降解脂质纳米颗粒。
Nat Commun. 2014 Jun 27;5:4277. doi: 10.1038/ncomms5277.
2
Uptake and transfection efficiency of PEGylated cationic liposome-DNA complexes with and without RGD-tagging.有或没有RGD标记的聚乙二醇化阳离子脂质体-DNA复合物的摄取和转染效率。
Biomaterials. 2014 Jun;35(18):4996-5005. doi: 10.1016/j.biomaterials.2014.03.007. Epub 2014 Mar 21.
3
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates.用于在啮齿动物和非人类灵长类动物中进行有效和选择性 siRNA 递送的脂肽纳米颗粒。
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):3955-60. doi: 10.1073/pnas.1322937111. Epub 2014 Feb 10.
4
Delivery of therapeutic siRNA to the lung endothelium via novel Lipoplex formulation DACC.通过新型脂质体复合物配方DACC将治疗性小干扰RNA递送至肺内皮细胞。
Mol Ther. 2014 Apr;22(4):811-20. doi: 10.1038/mt.2013.291. Epub 2014 Jan 6.
5
Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.聚乙二醇密度和表面脂质对脂质-钙-磷纳米颗粒的药代动力学和生物分布的影响。
Biomaterials. 2014 Mar;35(9):3027-34. doi: 10.1016/j.biomaterials.2013.12.022. Epub 2014 Jan 2.
6
Advances in Lipid Nanoparticles for siRNA Delivery.脂质纳米颗粒在 siRNA 递送上的进展。
Pharmaceutics. 2013 Sep 18;5(3):498-507. doi: 10.3390/pharmaceutics5030498.
7
Gene-silencing potency of symmetric and asymmetric lipid-conjugated siRNAs and its correlation with dicer recognition.对称和非对称脂质缀合 siRNA 的基因沉默效力及其与 Dicer 的识别相关性。
Bioconjug Chem. 2013 Dec 18;24(12):2045-57. doi: 10.1021/bc400391n. Epub 2013 Dec 9.
8
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial.在健康志愿者中，一种 RNA 干扰药物对前蛋白转化酶枯草溶菌素/柯萨奇蛋白酶 9（PCSK9）合成和血清 LDL 胆固醇浓度的影响：一项随机、单盲、安慰剂对照、1 期临床试验。
Lancet. 2014 Jan 4;383(9911):60-68. doi: 10.1016/S0140-6736(13)61914-5. Epub 2013 Oct 3.
9
Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery.用于评估用于 siRNA 递送的脂质纳米颗粒的多参数方法。
Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):12881-6. doi: 10.1073/pnas.1306529110. Epub 2013 Jul 23.
10
Surfactant-free, lipo-polymersomes stabilized by iron oxide nanoparticles/polymer interlayer for synergistically targeted and magnetically guided gene delivery.无表面活性剂，由氧化铁纳米粒子/聚合物夹层稳定的脂多聚物囊泡用于协同靶向和磁导向基因传递。
Adv Healthc Mater. 2014 Feb;3(2):273-82. doi: 10.1002/adhm.201300122. Epub 2013 Jul 18.
Zotero 插件